Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non-Small-Cell Lung Cancer Reply

Harry J. M. Groen^*, Otila Dalesio, Andrew Vincent

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

Originele taal-2	English
Pagina's (van-tot)	2020-2021
Aantal pagina's	3
Tijdschrift	Journal of Clinical Oncology
Volume	30
Nummer van het tijdschrift	16
DOI's	https://doi.org/10.1200/JCO.2012.42.0455
Status	Published - 1-jun.-2012

Toegang tot document

@article{b108cbacadad44609a0a973d0a60f84c,

title = "Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non-Small-Cell Lung Cancer Reply",

keywords = "CELECOXIB, EXPRESSION",

author = "Groen, {Harry J. M.} and Otila Dalesio and Andrew Vincent",

year = "2012",

month = jun,

day = "1",

doi = "10.1200/JCO.2012.42.0455",

language = "English",

volume = "30",

pages = "2020--2021",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "AMER SOC CLINICAL ONCOLOGY",

number = "16",

}

TY - JOUR

T1 - Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non-Small-Cell Lung Cancer Reply

AU - Groen, Harry J. M.

AU - Dalesio, Otila

AU - Vincent, Andrew

PY - 2012/6/1

Y1 - 2012/6/1

KW - CELECOXIB

KW - EXPRESSION

U2 - 10.1200/JCO.2012.42.0455

DO - 10.1200/JCO.2012.42.0455

M3 - Letter

SN - 0732-183X

VL - 30

SP - 2020

EP - 2021

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

ER -